Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the vaccination of healthy pregnant swine to provide passive immunity against rotaviral diarrhea, colibacillosis and enterotoxemia due to…
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MOREOnce-a-day, broad spectrum antibiotic therapy containing orbifloxacin, ideal for cats and small dogs.
LEARN MOREFor treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, Streptococcus…
LEARN MOREFor treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
LEARN MORE